Casey Logan
Corporate Officer/Principal at TRAVERE THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Brown | M | 43 | 9 years | |
| Eric Dube | M | 51 | 5 years | |
| Patricia Bitar | F | 65 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 5 years |
| Chris Cline | M | 40 | 10 years | |
| Jeffrey Meckler | M | 57 | 10 years | |
| Gary Lyons | M | 73 | 10 years | |
| Robert C. Coates | M | - |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 15 years |
| Martin Mattingly | M | 66 | 10 years | |
| John Orwin | M | 59 | 7 years | |
| Anat Ashkenazi | F | 51 | 23 years | |
| Sandra E. Poole | F | 60 | 5 years | |
| Travis Coy | M | 43 | 21 years | |
| Elizabeth Reed | F | 53 | 7 years | |
| Ron Squarer | M | 57 | 7 years | |
| Roy Baynes | M | 69 | 8 years | |
| Ruth Williams-Brinkley | F | 72 | 3 years | |
| Gregory Brown | M | 70 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 4 years |
| William LaRue | M | 73 | 10 years | |
| Suzanne Bruhn | M | 60 | 4 years | |
| Tim Coughlin | M | 57 | 9 years | |
| Mark Joseph Cantwell | M | 54 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Jon Fyrwald | M | 63 | 19 years | |
| Stephen Worland | M | 66 | 9 years | |
| Sandra Calvin | F | 59 | 10 years | |
| Steven Whitley | M | - |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Angela Giannantonio | F | - | - | |
| Jula Inrig | M | 49 | 2 years | |
| Charlotte Smith | F | - | - | |
| Bill Rote | M | 61 | 7 years | |
| Edgardo Hernandez | M | - | 19 years | |
| Peter Heerma | M | 53 | 5 years | |
| John Poulos | M | 70 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 4 years |
| Naomi Eichenbaum | F | - | - | |
| Christopher J. Pagano | M | 60 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Nivi Nehra | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Aselage | M | 73 | 10 years | |
| Paul Grayson | M | - |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | 12 years |
| Ronak H. Shah | M | - | 3 years | |
| Katherine Bowdish | M | 67 |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | - |
| Ellen Marram | F | 77 | 17 years | |
| Martin Feldstein | M | 84 | 10 years | |
| KULDEEP NEOTE | M | - | 17 years | |
| Michael Ackermann | M | - | 2 years | |
| Kenji Harada | M | 64 | 4 years | |
| Paul Walker | M | 49 | - | |
| Alfred Scheidegger | M | 67 | 2 years | |
| Laura Clague | F | 64 | 8 years | |
| Rolf K. Hoffmann | M | 64 | 17 years | |
| John Kozarich | M | 74 | 5 years | |
| Pedro Granadillo | M | 77 | 34 years | |
| Hironori Hozoji | M | 63 | 4 years | |
| James T. Glover | M | 74 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 3 years |
| Derica Rice | M | 59 | 14 years | |
| Jeffrey Henderson | M | 59 | 7 years | |
| Webster Dunbar | M | 62 | 5 years | |
| Freda Lewis-Hall | M | 69 | 8 years | |
| Gary D. Tollefson | M | 72 | 13 years | |
| Cezary Nadecki | M | - | 2 years | |
| Charl van Zyl | M | 57 | 9 years | |
| Robert Baughman | M | - | - | |
| Armen Shanafelt | M | 64 | 7 years | |
| Scott M. Stiffler | M | 54 | 7 years | |
| Candace Brandt | F | - | 3 years | |
| Bing Li | M | 55 | 7 years | |
| James A. Harper | M | 77 | 10 years | |
| James Anderson | M | 74 | 4 years | |
| Andrea Cranfill | F | - | 1 years | |
| Ford R. Lynch | M | 77 | 11 years | |
| Carl L. McMillian | M | 60 | - | |
| Michael Overdorf | M | 54 | 19 years | |
| Yao Chang Xu | M | 67 | 13 years | |
| Adam Houghton | M | - | 10 years | |
| Julie Gilmore | M | - | - | |
| Richard Buckley | M | 55 | 7 years | |
| Jesper Gromada | M | - | 6 years | |
| Charles Schalliol | M | 76 | 25 years | |
| Lori Queisser | F | 63 | 5 years | |
| Neal Fowler | M | 62 | 13 years | |
| Vanessah Ng | F | - | - | |
| Steven C. Beering | M | 91 | - | |
| J. Michael Cook | M | 81 | 4 years | |
| Charles E. Golden | M | 76 | 10 years | |
| Franklin P. Bymaster | M | 78 | - | |
| John Edward Victor Rose | M | 72 | - | |
| David A. Broecker | M | 63 | 16 years | |
| Brett L. Schmidli | M | 72 | 10 years | |
| Morris Z. Rosenberg | M | 64 | 3 years | |
| Thomas Verhoeven | M | - | - | |
| Joseph Zakrzewski | M | 60 | 16 years | |
| James C. Lancaster | M | 77 | 6 years | |
| Alan Breier | M | - | - | |
| Arnold A. Pinkston | M | 65 | 11 years | |
| Pierre V. Trân | M | 64 | 12 years | |
| James Posada | M | - | 4 years | |
| David Thompson | M | 76 | 34 years | |
| Homer Pearce | M | 71 | 27 years | |
| Jerome H. Fleisch | M | - | 27 years | |
| Martin F. Haslanger | M | - | 9 years | |
| Richard DiMarchi | M | 71 | 11 years | |
| Mark Andersen | M | 53 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Casey Logan
- Personal Network
